Stock Rich List
#5362 on the rich list of 14,452 insiders

Jason Coloma V.

Director at Braveheart Bio; Chief Executive Officer at Maze Therapeutics. Based in South San Francisco, California.

$19.2M
in disclosed stock, +$731K (+3.95%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
5362nd of 14,452
Companies held
2
Largest holding
MAZE, 90.6% of total
Latest SEC filing
Nov 2, 2026
Listed but not counted
$17.6M

What the $19.2M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Maze Therapeutics MAZE
Common Stock
Coloma Family Trust287,171$32.43$9.3M48.4%Form 4, Jul 1, 2026
Maze Therapeutics MAZE
Common Stock
Coloma Family Trust186,901$32.43$6.1M31.5%Form 4, Nov 2, 2026
Braveheart Bio BRVE
Common Stock
Through The Coloma 2021 Irrevocable Family Trust f/b/o Miles Coloma u/a/d 9/20/202193,607$19.27$1.8M9.4%Form 3, Aug 5, 2026
Maze Therapeutics MAZE
Common Stock
Directly27,362$32.43$887K4.6%Form 4, Oct 1, 2026
Maze Therapeutics MAZE
Common Stock
The Coloma 2021 Irrevocable Trust23,337$32.43$757K3.9%Form 4, Jul 1, 2026
Maze Therapeutics MAZE
Common Stock
The Coloma 2021 Irrevocable Trust12,965$32.43$420K2.2%Form 4, Nov 2, 2026

Share counts are the amounts Jason Coloma V. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Jason Coloma V.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Braveheart Bio BRVE
Common Stock
Through Westport Meridian Capital LP
Held by an investment fund or partnership
913,242$19.27$17.6M—Form 3, Aug 5, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 2, 2026SoldMAZE2,257$30.12$68KView
Nov 2, 2026SoldMAZE336$30.91$10KView
Nov 2, 2026SoldMAZE26,563$30.10$799KView
Nov 2, 2026SoldMAZE5,345$31.05$166KView
Oct 1, 2026SoldMAZE2,593$27.02$70KView
Oct 1, 2026SoldMAZE31,908$27.02$862KView
Sep 3, 2026SoldMAZE129$25.77$3KView
Sep 3, 2026SoldMAZE11,282$26.01$293KView
Sep 2, 2026SoldMAZE1,375$27.12$37KView
Sep 2, 2026SoldMAZE9,852$26.38$260KView
Sep 1, 2026SoldMAZE2,593$26.31$68KView
Sep 1, 2026SoldMAZE31,908$26.29$839KView
Aug 3, 2026SoldMAZE2,439$26.71$65KView
Aug 3, 2026SoldMAZE154$27.09$4KView
Aug 3, 2026SoldMAZE30,304$26.71$809KView
Aug 3, 2026SoldMAZE1,604$27.09$43KView
Jul 1, 2026SoldMAZE1,597$30.44$49KView
Jul 1, 2026SoldMAZE2,593$29.98$78KView
Jul 1, 2026SoldMAZE30,311$29.95$908KView
Jun 23, 2026SoldMAZE23,865$26.05$622KView
Jun 22, 2026SoldMAZE1,953$26.00$51KView
Jun 22, 2026SoldMAZE2,040$26.00$53KView
Jun 1, 2026SoldMAZE6,090$26.20$160KView
Jun 1, 2026SoldMAZE553$26.24$15KView
May 26, 2026SoldMAZE25,582$26.02$666KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
5359Ronald M. Lombardi
Chief Executive Officer, Prestige Consumer Healthcare. Tarrytown, NY
$19.3M−$397K (−2.02%)
5360Charles Lynn Hamilton
Chief Site Development Officer, Fermi. Amarillo, TX
$19.3M−$3.7M (−16.26%)
5361Shailesh Jejurikar
Chairman, President and CEO, The Procter & Gamble. Cincinnati, OH
$19.3M−$280K (−1.43%)
5362Jason Coloma V.
Director, Braveheart Bio. South San Francisco, CA
$19.2M+$731K (+3.95%)
5363Brian E. O.'Toole
CEO and President, BlackSky Technology. Herndon, VA
$19.2M−$1.9M (−9.01%)
5364David R. Lukes
President & CEO, Curbline Properties. New York, NY
$19.2M−$277K (−1.42%)
5365John Drayton Wise
Chief Commercial Officer, Insmed. Bridgewater, NJ
$19.2M+$3.3M (+20.58%)

Other Braveheart Bio insiders

All BRVE insiders

Questions

How much stock does Jason Coloma V. own?

Jason Coloma V. holds $19,242,585 in listed stock based on SEC filings and current prices, mostly Maze Therapeutics (MAZE). That ranks 5362nd on the Stock Rich List.

Is this Jason Coloma V.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Jason Coloma V. last buy or sell stock?

The most recent open-market trade on file is a sale of 2,257 MAZE shares on Nov 2, 2026 at $30.12.